MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The interplay between cholinergic activity, attention, and turning in Parkinson’s disease

    R. Morris, D. Martini, G. Mcbarron, M. Mancini, F. Horak (Portland, OR, USA)

    Objective: Explore how cholinergic activity (measured by short latency afferent inhibition [SAI]) and attention relate to quality of turning performance over a week of daily…
  • 2019 International Congress

    The utility of DCTclock™ (the digital clock drawing test) for unmasking early cognitive decline in Parkinson’s disease

    T. Schejter Margalit, R. Kizony, B. Cohen, A. Thaler, W. Souillard-Mandar, A. Holway, V. Irzhevsky, A. Orr-Urtreger, J. Cederbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To examine the utility of DCTclock, for assessing subtle cognitive impairments in early Parkinson's disease (PD). Background: The identification of cognitive decline is crucial…
  • 2019 International Congress

    Accuracy of the MoCA in Detecting PD-MCI in the Ontario Neurodegenerative Disease Research Initiative study

    KB. Zaidi, C. Marras, A. Troyer, A. Lang, M. Masellis, D. Grimes, D. Kwan, JB. Orange, A. Roberts, B. Levine, M. Jog, T. Steeves, B. Tan, P. Mclaughlin (Toronto, ON, Canada)

    Objective: To investigate the ability of the Montreal Cognitive Assessment (MoCA) to detect mild cognitive impairment (MCI) in Parkinson’s disease (PD) using variations in cognitive…
  • 2019 International Congress

    RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.

    K. Irmady, C. Hale, C. Scheckel, J. Fak, R. Darnell (New York, NY, USA)

    Objective: To investigate the role of RNA binding protein Elavl in Parkinson’s disease related adaptive changes in the striatal transcriptome. Background: Elav-like (Elavl or Hu)…
  • 2019 International Congress

    Weighting fibroblasts for future diagnostic prospect

    G. Prevot, E. Bezard, L. Cognet, B. Dehay, P. Bon (Bordeaux, France)

    Objective: To determine the dry mass of fibroblasts obtained from apparently healthy individuals and patients with brain disorders or cancer pathologies for future diagnosis prospect.…
  • 2019 International Congress

    Advanced Stage of Parkinson’s Disease: From Identification to Characterization and Disease Burden Assessment Using a Nationwide Database

    Y. Barer, T. Gurevich, G. Chodick, N. Giladi, R. Gross, R. Cohen, L. Bergmann, Y. Jalundhwala, V. Shalev, A. Thaler (Tel Aviv-Yafo, Israel)

    Objective: To identify and describe PD patients who were prescribed intensified therapy and compare their burden of disease with mild-moderate PD patients. Background: Real-world data…
  • 2019 International Congress

    Gender-dependent improvement in the survival of Parkinson’s disease patients in Finland

    T. Kuusimäki, S. Kurki, J. Sipilä, H. Salminen-Mankonen, O. Carpén, V. Kaasinen (Turku, Finland)

    Objective: To longitudinally investigate the overall survival (OS) of a large cohort of Parkinson's disease (PD) patients. Background: While there is evidence of increasing incidence,…
  • 2019 International Congress

    Expenditures on pesticides and incidence of Parkinson’s disease in French farmers: a nationwide study

    L. Perrin, J. Spinosi, L. Chaperon, S. Kab, F. Moisan, A. Elbaz (Villejuif Cedex, France)

    Objective: We examined the association between expenditures on pesticides for several agricultural activities and incidence of Parkinson’s disease (PD) in French farmers. Background: Epidemiological studies…
  • 2019 International Congress

    Prevalence and clinical characteristics of Parkinson Disease in Chernivtsi Region of Ukraine

    O. Yaremchuk, I. Yaremchuk (Chernivtsi, Ukraine)

    Objective: The aim of this study was to investigate prevalence and clinical characteristics of Parkinson’s disease (PD) in the Chernivtsi region of Ukraine among different…
  • 2019 International Congress

    Registration Algorithm of DBS Preoperative Image and ICBM-152 Atlas

    H. Zheng, S. Luo, S. Cao, D. Huang, C. Xu (Nanjing, China)

    Objective: As we all know, there would be some distortions of electrodes or even distortions of patient's brain images when matching the brain atlases with…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley